ProQR Therapeutics NV (PRQR)
3.60
-0.03
(-0.83%)
USD |
NASDAQ |
Nov 05, 16:00
3.60
0.00 (0.00%)
After-Hours: 18:13
ProQR Therapeutics Enterprise Value: 198.19M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 198.19M |
| November 01, 2024 | 206.36M |
| October 31, 2024 | 187.57M |
| October 30, 2024 | 200.64M |
| October 29, 2024 | 183.49M |
| October 28, 2024 | 172.05M |
| October 25, 2024 | 184.30M |
| October 24, 2024 | 183.49M |
| October 23, 2024 | 186.75M |
| October 22, 2024 | 210.44M |
| October 21, 2024 | 232.49M |
| October 18, 2024 | 255.36M |
| October 17, 2024 | 268.43M |
| October 16, 2024 | 230.04M |
| October 15, 2024 | 49.53M |
| October 14, 2024 | 49.53M |
| October 11, 2024 | 52.80M |
| October 10, 2024 | 55.25M |
| October 09, 2024 | 54.43M |
| October 08, 2024 | 54.43M |
| October 07, 2024 | 60.97M |
| October 04, 2024 | 60.97M |
| October 03, 2024 | 50.35M |
| October 02, 2024 | 55.25M |
| October 01, 2024 | 45.45M |
| Date | Value |
|---|---|
| September 30, 2024 | 50.35M |
| September 27, 2024 | 51.16M |
| September 26, 2024 | 47.08M |
| September 25, 2024 | 48.71M |
| September 24, 2024 | 38.91M |
| September 23, 2024 | 38.91M |
| September 20, 2024 | 43.00M |
| September 19, 2024 | 47.08M |
| September 18, 2024 | 48.71M |
| September 17, 2024 | 51.16M |
| September 16, 2024 | 51.16M |
| September 13, 2024 | 52.80M |
| September 12, 2024 | 52.80M |
| September 11, 2024 | 52.80M |
| September 10, 2024 | 51.98M |
| September 09, 2024 | 51.98M |
| September 06, 2024 | 53.21M |
| September 05, 2024 | 55.66M |
| September 04, 2024 | 56.47M |
| September 03, 2024 | 58.52M |
| August 30, 2024 | 66.68M |
| August 29, 2024 | 64.23M |
| August 28, 2024 | 63.42M |
| August 27, 2024 | 65.05M |
| August 26, 2024 | 69.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-99.27M
Minimum
Mar 25 2022
448.31M
Maximum
Dec 16 2019
124.99M
Average
116.72M
Median
Nov 19 2020
Enterprise Value Benchmarks
| uniQure NV | -150.68M |
| Merus NV | 2.874B |
| argenx SE | 32.06B |
| Pharming Group | 488.90M |
| Pharvaris NV | 926.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.899M |
| Revenue (Quarterly) | 6.789M |
| Total Expenses (Quarterly) | 10.83M |
| EPS Diluted (Quarterly) | -0.0323 |
| Profit Margin (Quarterly) | -42.70% |
| Earnings Yield | -7.82% |
| Normalized Earnings Yield | -9.092 |